Life Technologies, EdgeBio Team with VCU on Schizophrenia Markers | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies will partner with EdgeBio and Virginia Commonwealth University in a project that will study how gene regulation and epigenetic markers may be involved in the development of schizophrenia.

The research will involve using Life Technologies' SOLiD System and MethylMiner methylated DNA enrichment kit to conduct genome-wide sequencing and methylation studies of 1,500 individuals, the company said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.